SA
Shilanski & Associates’s Pfizer PFE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-95,965
| Closed | -$2.66M | – | 114 |
|
|
2024
Q1 | $2.66M | Buy |
95,965
+2,770
| +3% | +$76.9K | 0.92% | 37 |
|
|
2023
Q4 | $2.68M | Buy |
93,195
+751
| +0.8% | +$21.6K | 1.02% | 31 |
|
|
2023
Q3 | $3.07M | Buy |
92,444
+2,908
| +3% | +$96.5K | 1.25% | 29 |
|
|
2023
Q2 | $3.28M | Buy |
89,536
+2,435
| +3% | +$89.3K | 1.33% | 26 |
|
|
2023
Q1 | $3.62M | Buy |
87,101
+2,154
| +3% | +$89.5K | 1.63% | 24 |
|
|
2022
Q4 | $4.35M | Buy |
84,947
+77,892
| +1,104% | +$3.99M | 1.9% | 13 |
|
|
2022
Q3 | $309K | Sell |
7,055
-74,057
| -91% | -$3.24M | 0.11% | 99 |
|
|
2022
Q2 | $4.25M | Buy |
81,112
+1,553
| +2% | +$81.4K | 1.99% | 14 |
|
|
2022
Q1 | $4.12M | Sell |
79,559
-1,673
| -2% | -$86.6K | 1.73% | 18 |
|
|
2021
Q4 | $4.8M | Sell |
81,232
-2,298
| -3% | -$136K | 2.04% | 13 |
|
|
2021
Q3 | $3.59M | Buy |
83,530
+2,096
| +3% | +$90.2K | 1.67% | 20 |
|
|
2021
Q2 | $3.19M | Buy |
81,434
+1,996
| +3% | +$78.2K | 1.51% | 26 |
|
|
2021
Q1 | $2.88M | Sell |
79,438
-6,714
| -8% | -$243K | 1.54% | 27 |
|
|
2020
Q4 | $3.17M | Buy |
86,152
+1,677
| +2% | +$61.7K | 1.93% | 16 |
|
|
2020
Q3 | $3.1M | Sell |
84,475
-57
| -0.1% | -$2.09K | 2.1% | 13 |
|
|
2020
Q2 | $2.76M | Buy |
84,532
+2,380
| +3% | +$77.8K | 2.01% | 13 |
|
|
2020
Q1 | $2.68M | Buy |
82,152
+2,837
| +4% | +$92.6K | 2.69% | 13 |
|
|
2019
Q4 | $3.11M | Buy |
79,315
+899
| +1% | +$35.2K | 2.39% | 17 |
|
|
2019
Q3 | $2.82M | Buy |
78,416
+1,978
| +3% | +$71.1K | 2.27% | 17 |
|
|
2019
Q2 | $3.31M | Buy |
+76,438
| New | +$3.31M | 2.68% | 12 |
|